Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy

Purpose. The aim was to evaluate the efficacy of aflibercept in patients with diabetic macular edema (DME) unresponsive to prior anti-VEGF therapy. Methods. Retrospective review of DME unresponsive to previous anti-VEGF switched to aflibercept with 3 months of follow-up. Changes in best correct visu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mira, Filipe, Paulo, Manuel, Henriques, Filipe, Figueira, João
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350533/
https://www.ncbi.nlm.nih.gov/pubmed/28348885
http://dx.doi.org/10.1155/2017/5632634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350533/
https://www.ncbi.nlm.nih.gov/pubmed/28348885
http://dx.doi.org/10.1155/2017/5632634

Ejemplares similares